Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review
- 1 May 2000
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 54 (4), 210-218
- https://doi.org/10.1016/s0753-3322(00)89027-7
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Routine and Influenza Vaccination Rates in Children with AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Influenza VaccinesDrugs, 1997
- Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly PatientsThe Journal of Infectious Diseases, 1997
- Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and EfficacyThe Journal of Infectious Diseases, 1996
- Sickness Absence Following a Campaign of Vaccination against Influenza in the WorkplaceOccupational Medicine, 1996
- The HA1 of cold-adapted influenza B vaccine is not altered during replication in human vaccineesVirus Research, 1995
- Increased Anti-Influenza A Virus Cytotoxic T Cell Activity following Vaccination of the Chronically III Elderly with Live Attenuated or Inactivated Influenza Virus VaccineThe Journal of Infectious Diseases, 1995
- Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza VaccinesThe Journal of Infectious Diseases, 1993
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983
- Interpandemic Influenza in the Houston Area, 1974–76New England Journal of Medicine, 1978